AlphaQuest LLC Raises Position in DaVita Inc. $DVA

AlphaQuest LLC grew its position in DaVita Inc. (NYSE:DVA) by 2,314.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 22,820 shares of the company’s stock after purchasing an additional 21,875 shares during the quarter. AlphaQuest LLC’s holdings in DaVita were worth $2,593,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. NewEdge Advisors LLC raised its holdings in DaVita by 20.8% in the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after buying an additional 88 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of DaVita by 34.9% during the third quarter. Smartleaf Asset Management LLC now owns 452 shares of the company’s stock valued at $59,000 after purchasing an additional 117 shares during the last quarter. Bank of Nova Scotia raised its holdings in shares of DaVita by 2.5% during the third quarter. Bank of Nova Scotia now owns 4,933 shares of the company’s stock valued at $655,000 after purchasing an additional 120 shares during the last quarter. Daiwa Securities Group Inc. raised its holdings in shares of DaVita by 2.2% during the second quarter. Daiwa Securities Group Inc. now owns 6,502 shares of the company’s stock valued at $926,000 after purchasing an additional 138 shares during the last quarter. Finally, State of Wyoming raised its holdings in shares of DaVita by 6.0% during the second quarter. State of Wyoming now owns 2,759 shares of the company’s stock valued at $393,000 after purchasing an additional 156 shares during the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Performance

Shares of NYSE:DVA opened at $195.66 on Wednesday. The firm has a fifty day moving average price of $164.74 and a 200 day moving average price of $139.34. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $202.69. The firm has a market cap of $12.56 billion, a price-to-earnings ratio of 18.15, a P/E/G ratio of 0.65 and a beta of 0.84.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same quarter last year, the firm earned $2.00 EPS. The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, research analysts predict that DaVita Inc. will post 15.07 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on DVA shares. Zacks Research raised shares of DaVita from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. Barclays upped their target price on shares of DaVita from $158.00 to $194.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. UBS Group upped their target price on shares of DaVita from $190.00 to $235.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Deutsche Bank Aktiengesellschaft raised shares of DaVita from a “hold” rating to a “buy” rating and upped their target price for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $199.17.

Insider Activity at DaVita

In other news, CFO Joel Ackerman sold 51,471 shares of the firm’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the sale, the chief financial officer owned 132,434 shares in the company, valued at approximately $25,440,571.40. This trade represents a 27.99% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.50% of the company’s stock.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.